TY  - JOUR
AU  - Leon-Jimenez, David
AU  - Gómez-Huelgas, Ricardo
AU  - Miramontes-Gonzalez, Jose Pablo
PY  - 2018
DO  - 10.1002/ejhf.1068
UR  - http://hdl.handle.net/10668/11843
T2  - European journal of heart failure
AB  - Butler et al.,1 in their review about the poten-tial role of sodium–glucose co-transporter-2inhibitors (SGLT2i) in the treatment of heartfailure (HF), do not mention the carbonicanhydrase (CA) inhibitors, whose mechanismof action has remarkable...
LA  - en
PB  - European Society of Cardiology
KW  - Sodium-Glucose Transporter 2
KW  - Natriuretic Agents
KW  - Diuretics
KW  - Hyperglycemia
KW  - Sodium-Glucose Transport Proteins
KW  - Glucose
KW  - Carbonic Anhydrase Inhibitors
KW  - Glucose
KW  - Heart Failure
KW  - Humans
KW  - Sodium
KW  - Sulfonamides
KW  - Symporters
TI  - The mechanism of action of sodium-glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors.
TY  - research article
VL  - 20
ER  -